It appears hedge funds and other sophisticated investors piled into bets against small-cap stocks at exactly the wrong time. On Thursday, they paid the price as traders dumped market-leading Big Tech ...

Korro Bio, Inc., a biopharmaceutical company, engages in the discovering, developing, and commercializing of genetic medicines based on editing RNA for the treatment of rare and highly prevalent ...